LAXMI DENTAL LIMITED·Healthcare Companies·Healthcare Equipment & Supplies Companies

2026-08-21 NSE BSE Web 20% Result 11 Aug

Price

198.14

-0.03%
O:199.69
H:201
L:197.52
C:198.14

52W Range

155.88377.05
+27%/-47%

Market Cap

₹1,089.02 Cr

Traded: ₹1.08 Cr (0.10%) 0.0x

Free Float: ₹179.69 Cr (0.60% of FF traded)

Volume · 60D trend

54.29 K 0.0x

Delivery: % 0.0x

View Delivery Data

Returns

1W:+0% 1M:-7% 3M:-11% 6M:+2% 12M:-26%

Valuation

P/E35.3
P/B4.5
P/S3.8
EV/EBIT55.8

Business Strength

ROE22.5%
ROCE18.7%
OPM15.5%
NPM10.4%

Growth (3Y CAGR)

EPS-8.8%
Sales+20.0%
Profit+124.0%
3Y Return--

Balance Sheet

Debt/Equity-0.0
Debt-0.01 Cr
Pledge0.0%
CWIP/Fixed Asset0.0%

Cash Position

CFO/NP-17.2%
FCF-23 Cr
FCF 3Y Avg0.16 Cr
Cash/MCap4.0%

Others

Div Yield0.0%
Div Payout0.0%
Cash Conv. Cycle109 days
Tradeable Free Float16.5%

MTF Exposure Trend

60 sessions · funded amount, % of FF, daily delta

Current
₹ 10.29 Cr
5.73% FF
60d high
₹ 11.19 Cr
60d low
₹ 5.76 Cr
60d mean
₹ 7.73 Cr
vs mean
▲ 33.24%

Growth Trends

Metric10Y5Y3Y1YTTMTrend
ROE
--
+18.0%
+23.0%
--
--
Accelerating
Sales
--
+25.0%
+20.0%
--
+16.0%
Decelerating
Profit
--
+103.0%
+124.0%
--
+28.0%
Stable
Return
--
--
--
-37.0%
--
--

Quarterly Results

Jun 2026

11 Aug
Rev
75 Cr
+14% YoY--
OPM19.0%
NPM--
PAT
+23% YoY10 Cr
EPS
--1.9

Mar 2026

22 May
Rev
74 Cr
+22% YoY+12% QoQ
OPM18.0%
NPM13.5%
PAT
+150% YoY10 Cr
EPS
+135% YoY1.8

Dec 2025

10 Feb
Rev
66 Cr
+7% YoY-8% QoQ
OPM11.0%
NPM3.0%
PAT
+22% YoY2 Cr
EPS
-61% YoY0.4

Sep 2025

PDF
Rev
72 Cr
+27% YoY+9% QoQ
OPM15.0%
NPM12.5%
PAT
+45% YoY9 Cr
EPS
-27% YoY1.6

Jun 2025

PDF
Rev
66 Cr
+10% YoY+8% QoQ
OPM18.0%
NPM12.1%
PAT
-28% YoY8 Cr
EPS
-75% YoY1.5

Mar 2025

PDF
Rev
61 Cr
+10% YoY-2% QoQ
OPM16.0%
NPM6.6%
PAT
-51% YoY4 Cr
EPS
-100% YoY0.8

Dec 2024

PDF
Rev
62 Cr
+29% YoY+9% QoQ
OPM16.0%
NPM8.1%
PAT
+70% YoY5 Cr
EPS
-99% YoY0.9

Sep 2024

Rev
57 Cr
---5% QoQ
OPM15.0%
NPM10.5%
PAT
--6 Cr
EPS
--2.1

Jun 2024

Rev
60 Cr
--+9% QoQ
OPM23.0%
NPM28.3%
PAT
--17 Cr
EPS
--6.0

Mar 2024

Rev
55 Cr
--+15% QoQ
OPM21.0%
NPM14.6%
PAT
--8 Cr
EPS
--243.9

Dec 2023

Rev
48 Cr
----
OPM8.0%
NPM4.2%
PAT
--2 Cr
EPS
--74.0

Revenue & Margin Trends

Annual

Quarterly

Balance Sheet Health

Leverage

Debt / Equity0.05
Interest Coverage-0.8x
Promoter Pledge0.0%
Borrowings13 Cr

Efficiency

Receivable Days60 days
Inventory Days97 days
Payable Days47 days
Cash Conversion cycle109 days

Cash Position

Operating Cash Flow-5 Cr
Investing Cash Flow-80 Cr
Financing Cash Flow-18 Cr
Free Cash Flow-23 Cr

Detailed Financials

Jun 2026PDF ↗
Mar 2026PDF ↗
Dec 2025PDF ↗
Sep 2025PDF ↗
Jun 2025PDF ↗
Mar 2025PDF ↗
Dec 2024PDF ↗
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sales7574667266616257605548
Expenses6060596154515248464344
Operating Profit1414711121010914124
OPM %19.0%18.0%11.0%15.0%18.0%16.0%16.0%15.0%23.0%21.0%8.0%
Other Income22-422211600
Interest00000121111
Depreciation44444443333
Profit Before Tax1211-1910655167-1
Tax %21.0%4.0%-175.0%20.0%24.0%41.0%23.0%23.0%11.0%16.0%-140.0%
Net Profit10102984561782
Exceptional Items--0-6000006-1-1
EPS (Rs)1.91.80.41.61.50.80.92.16.0243.974.0
Sales Growth (YoY)13.9%21.9%7.1%26.5%9.9%10.2%29.0%--------
Sales Growth (QoQ)--12.1%-8.3%9.1%8.2%-1.6%8.8%-5.0%9.1%14.6%--
OP Growth (YoY)16.7%40.0%-30.0%22.2%-14.3%-16.7%150.0%--------
OP Growth (QoQ)0.0%100.0%-36.4%-8.3%20.0%0.0%11.1%-35.7%16.7%200.0%--
Profit Growth (YoY)22.8%149.5%22.3%44.8%-27.8%-50.7%70.0%--------
EPS Growth (YoY)--134.6%-61.3%-26.9%-74.7%-99.7%-98.7%--------
EPS Growth (QoQ)--408.3%-76.8%1.3%96.2%-16.1%-56.1%-64.9%-97.5%229.4%--
OP Margin--18.9%10.6%15.3%18.2%16.4%16.1%15.8%23.3%21.8%8.3%
Net Margin--13.5%3.0%12.5%12.1%6.6%8.1%10.5%28.3%14.6%4.2%
Material Cost %21.4%29.5%30.4%31.5%26.7%21.3%26.1%24.3%24.1%22.4%27.8%
Employee Cost %38.0%36.2%39.3%35.7%36.0%40.2%35.3%36.0%29.8%34.8%38.1%
P/S3.794.174.324.07--------------
P/E35.3239.9949.2340.20--------------
P/B4.484.774.994.62--------------

Shareholding Pattern

Shareholders:38.2K (+29.4%)
Current MixMar 2026

Exchange Filings

50
Company Update19 Aug 2026

Earnings Call Transcript Q1FY27

Company Update13 Aug 2026

Extract of newspaper advertisements published on August 13, 2026, in the Financial Express (English Newspaper) and Mumbai Lakshdeep (Marathi Newspaper), with respect to Unaudited Standalone ....

Company Update12 Aug 2026

Q1FY27 Earnings Conference Call Recordings

Company Update11 Aug 2026

Earnings call Presentation.

Company Update11 Aug 2026

Intimation of Monitoring Agency Report for the quarter ended June 30, 2026.

Company Update11 Aug 2026

Intimation of Press Release

Company Update11 Aug 2026

Board of Directors at its meeting held today, August 11, 2026 has noted and approved surrender of 1,636 ESOP from Mr. Ansari Mohammed Saad.

Company Update11 Aug 2026

Allotment of 59,360 Equity Shares of face value of INR. 2 each under Laxmi Dental Stock Options Scheme 2024.

Result11 Aug 2026

Declaration of Unaudited Financial Results for the quarter ended June 30, 2026.

Board Meeting11 Aug 2026

Outcome of Board Meeting of Laxmi Dental Limited held on Tuesday, August 11, 2026 for approval of un-audited financial results (standalone and consolidated) for the quarter ended June 30, ....

Company Update07 Aug 2026

Pursuant to the Regulation 30(6), read with Schedule III Part A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, this is to ....

Board Meeting07 Aug 2026

Laxmi Dental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the unaudited standalone and consolidated ....

Company Update10 Jul 2026

Intimation on disbursement of unsecured loan of INR. 25 Lakhs to Signature Smiles Dental Clinic Private Limited, Subsidiary Company in accordance with Loan Agreement dated December 29, ....

Company Update08 Jul 2026

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30, 2026.

Company Update30 Jun 2026

Pursuant to the Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, as amended from time to time, it is hereby ....

Insider Trading / SAST26 Jun 2026

Intimation of Closure of Trading Window for quarter ended June 30, 2026.

Company Update18 Jun 2026

Pursuant to the Regulation 30 read with Para A Part A Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, as amended from time to time, it is hereby ....

Company Update30 May 2026

We submit herewith the Annual Secretarial Compliance Report for the financial year ended March 31, 2026, issued by M/s. M. Jawadwala & Co., Practicing Company Secretaries.

Company Update30 May 2026

Earnings Call Transcript

Company Update23 May 2026

Extract of newspaper advertisements published on May 23, 2026, in the Financial Express (English Newspaper) and Mumbai Lakshdeep (Marathi Newspaper), with respect to Audited Standalone ....

Company Update22 May 2026

Q4FY26 Earnings Conference Call Recordings

Company Update22 May 2026

Earnings call Presentation

Company Update22 May 2026

Intimation of Press Release

Result21 May 2026

Declaration of Audited Financial Results for the quarter and financial year ended March 31, 2026.

Board Meeting21 May 2026

Outcome of Board Meeting of Laxmi Dental Limited held on Thursday, May 21, 2026 for approval of audited financial results (standalone and consolidated) for the quarter and financial year ....

Company Update18 May 2026

Pursuant to the Regulation 30(6), read with Schedule III Part A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, this is to ....

Board Meeting18 May 2026

Laxmi Dental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve the Audited Financial Results ....

Company Update07 May 2026

Intimation of Monitoring Agency Report for the quarter ended March 31, 2026.

Company Update17 Apr 2026

Intimation of Schedule of Analyst / Institutional Investor meetings under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015

Company Update10 Apr 2026

Intimation of In-principle approval received from BSE for listing of Equity Shares under Laxmi Dental Employee Stock Option Scheme 2024.

Company Update09 Apr 2026

Intimation of In-principle approval received from NSE for listing of Equity Shares under Laxmi Dental Employee Stock Option Scheme 2024.

Company Update04 Apr 2026

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st March, 2026.

Insider Trading / SAST01 Apr 2026

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sameer Kamlesh Merchant

Company Update26 Mar 2026

Board of Directors at its meeting held today i.e Thursday, March 26, 2026 has approved the following: 1. Re-appointment of M/s. Abhay Subhash & Associates as the Tax Auditor of the Company ....

Company Update26 Mar 2026

Board of Directors at its meeting held today i.e Thursday, March 26, 2026 has approved Scheme of Amalgamation between Bizdent Devices Private Limited, Wholly owned subsidiary company (Transferor ....

Company Update26 Mar 2026

Board of Directors at its meeting held today, March 26, 2026 has noted and approved surrender of 32538 ESOP from Mr. Mitesh Kariya.

Insider Trading / SAST23 Mar 2026

Intimation of Closure of Trading Window for quarter and financial year ended March 31, 2026.

Insider Trading / SAST02 Mar 2026

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sameer Kamlesh Merchant

Insider Trading / SAST28 Feb 2026

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sameer Kamlesh Merchant

Company Update27 Feb 2026

Pursuant to the Regulation 30 read with Para A Part A Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, as amended from time to time, it is hereby ....

Company Update26 Feb 2026

Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be participating ....

Insider Trading / SAST24 Feb 2026

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajesh Vrajlal Khakhar

Insider Trading / SAST24 Feb 2026

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajesh Vrajlal Khakhar

Insider Trading / SAST23 Feb 2026

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajesh Khakhar

Company Update17 Feb 2026

Transcript of the Q3FY26 Earnings Conference Call of Laxmi Dental Limited.

Company Update12 Feb 2026

Extract of newspaper advertisements published on February 12 2026, in the Financial Express (English Newspaper) and Mumbai Lakshadeep (Marathi Newspaper) with respect to Unaudited Standalone ....

Company Update11 Feb 2026

Q3FY26 Earnings Conference Call Recordings

Company Update10 Feb 2026

Intimation of Press Release.

Company Update10 Feb 2026

Earnings call Presentation

Company Update10 Feb 2026

Intimation of Monitoring Agency Report for the quarter ended December 31, 2025

Annual Reports

1

2025

Concalls

6

Feb 2026

28 Feb 2026

Nov 2025

30 Nov 2025

Aug 2025

31 Aug 2025

May 2025

31 May 2025

Feb 2025

28 Feb 2025

Feb 2025

28 Feb 2025

Held by ETFs

1 ETFs hold laxmidentl · sorted by weight

#ETFWeight %
1

MOHEALTH

MOTILALAMC - MOHEALTH

0.02%

Held by Mutual Funds

15 schemes hold laxmidentl · sorted by weight

#SchemeWeight %
1

Kotak Healthcare Fund

Kotak Mahindra Mutual Fund

1.18%
2

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund

ICICI Prudential Mutual Fund

0.77%
3

HDFC Pharma And Healthcare Fund

HDFC Mutual Fund

0.56%
4

ICICI Prudential Exports and Services Fund

ICICI Prudential Mutual Fund

0.51%
5

WhiteOak Capital Pharma and Healthcare Fund

WhiteOak Capital Mutual Fund

0.20%
6

Bank of India Conservative Hybrid Fund

Bank of India Mutual Fund

0.15%
7

HDFC Consumption Fund

HDFC Mutual Fund

0.25%
8

Tata ELSS Fund

Tata Mutual Fund

0.14%
9

Tata India Innovation Fund

Tata Mutual Fund

0.08%
10

WhiteOak Capital Multi Cap Fund

WhiteOak Capital Mutual Fund

0.07%
11

Bank of India Small Cap Fund

Bank of India Mutual Fund

0.40%
12

WhiteOak Capital Multi Asset Allocation Fund

WhiteOak Capital Mutual Fund

0.01%
13

WhiteOak Capital Balanced Advantage Fund

WhiteOak Capital Mutual Fund

0.04%
14

Bandhan BSE Healthcare Index Fund

Bandhan Mutual Fund

0.03%
15

WhiteOak Capital Balanced Hybrid Fund

WhiteOak Capital Mutual Fund

0.01%